Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-02

FDA Approved: LEVETIRACETAM — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Quagen Pharmaceuticals LLC, authorizing the generic product under an ANDA and enabling continued …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)